Phase I study of succinylated acinetobacter L-glutaminase-L-asparaginase

Myeloablative therapy with autologous stem cell rescue for patients with Ewing sarcoma.

Bone marrow transplantation·2008

Outcomes after HLA-matched sibling transplantation or chemotherapy in children with acute lymphoblastic leukemia in a second remission after an isolated central nervous system relapse: a collaborative study of the Children's Oncology Group and the Center for International Blood and Marrow Transplant Research.

Leukemia·2007

Bone marrow transplants from mismatched related and unrelated donors for severe aplastic anemia.

Bone marrow transplantation·2006

Alternative donor bone marrow transplant for children with Philadelphia chromosome ALL.

Bone marrow transplantation·2005

High concordance from independent studies by the Children's Cancer Group (CCG) and Pediatric Oncology Group (POG) associating favorable prognosis with combined trisomies 4, 10, and 17 in children with NCI Standard-Risk B-precursor Acute Lymphoblastic Leukemia: a Children's Oncology Group (COG) initiative.

Leukemia·2005

Second transplant for acute and chronic leukemia relapsing after first HLA-identical sibling transplant.

Bone marrow transplantation·2004

Cisplatin as a first-line treatment in T2 and T3 bladder carcinoma.

Cancer treatment reports·1987

IV melphalan in children.

Cancer treatment reports·1987

Interactions of methotrexate and cyclophosphamide with the pharmacokinetics of 5-fluorouracil in an animal model.

Cancer treatment reports·1987

Phase II trial of rDNA alfa 2b interferon in patients with malignant carcinoid tumor.

Cancer treatment reports·1987

Doxorubicin distribution in human breast cancer.

Cancer treatment reports·1987

Phase I study of echinomycin.

Cancer treatment reports·1987

Clinical characteristics and prognosis of IgA nephropathy and comorbid diabetic kidney disease.

Annals of medicine·2026

Measurement Invariance of the Brief State Rumination Inventory Across Administration Methods, National Samples, and Sex.

Journal of personality assessment·2026

Molecular Epidemiology and Phylogenetic Analysis of HTLV-1 in HIV-1-infected Patients in Tehran, Iran.

Journal of medical virology·2026

Is Insulin Resistance the Driver or the Outcome of Diabetes Mellitus? A Critical Review.

Journal of nutrition and metabolism·2026

Probiotic-Derived Extracellular Vesicles as Potential Nano-Immunotherapeutic Platforms in IBD: A Clinician's Perspective.

International journal of nanomedicine·2026

Tissue Inhibitor of Metalloproteinase 2 (TIMP 2) Promotor 418 G > C Polymorphism in Non-alcoholic Fatty Liver Disease (NAFLD) Patients of Eastern States of India.

Indian journal of clinical biochemistry : IJCB·2026

Related Experiment Videos

Phase I study of succinylated acinetobacter L-glutaminase-L-asparaginase

Related Concept Videos

Myeloablative therapy with autologous stem cell rescue for patients with Ewing sarcoma.

Bone marrow transplants from mismatched related and unrelated donors for severe aplastic anemia.

Alternative donor bone marrow transplant for children with Philadelphia chromosome ALL.

Second transplant for acute and chronic leukemia relapsing after first HLA-identical sibling transplant.

Cisplatin as a first-line treatment in T2 and T3 bladder carcinoma.

IV melphalan in children.

Interactions of methotrexate and cyclophosphamide with the pharmacokinetics of 5-fluorouracil in an animal model.

Phase II trial of rDNA alfa 2b interferon in patients with malignant carcinoid tumor.

Doxorubicin distribution in human breast cancer.

Phase I study of echinomycin.

Clinical characteristics and prognosis of IgA nephropathy and comorbid diabetic kidney disease.

Measurement Invariance of the Brief State Rumination Inventory Across Administration Methods, National Samples, and Sex.

Molecular Epidemiology and Phylogenetic Analysis of HTLV-1 in HIV-1-infected Patients in Tehran, Iran.

Is Insulin Resistance the Driver or the Outcome of Diabetes Mellitus? A Critical Review.

Probiotic-Derived Extracellular Vesicles as Potential Nano-Immunotherapeutic Platforms in IBD: A Clinician's Perspective.

Tissue Inhibitor of Metalloproteinase 2 (TIMP 2) Promotor 418 G > C Polymorphism in Non-alcoholic Fatty Liver Disease (NAFLD) Patients of Eastern States of India.

Related Experiment Videos

Phase I study of succinylated acinetobacter L-glutaminase-L-asparaginase

Related Concept Videos

Related Articles